Translational Aspects of Adeno-Associated Virus-Mediated Cardiac Gene Therapy

Human Gene Therapy
Tilman ZieglerChristian Kupatt

Abstract

Recombinant adeno-associated virus vectors (rAAVs) represent a reliable tool for basic and translational research, while rAAVs are also making strides in early clinical trials as vehicles for gene transfer. Their low immunogenicity, tissue tropism, and relative safety due to their low rate of genomic integration represent key features, making rAAVs promising instruments as vectors for future gene therapy approaches. Specifically, for cardiovascular gene therapy, rAAVs appear superior to other vector systems such as lenti- and adenoviral vectors due to the ease of accomplishing long-term cardiac expression of target genes and the reduced risk of provoking immune responses or triggering malignancies through genomic integration. However, major obstacles remain to be resolved if rAAVs are to achieve their full potential as gene therapy vectors in clinical trials. The main hurdles prohibiting their sustained success are their limited capacity to carry transgenes of larger sizes, the prevalence of neutralizing antibodies in the general population, and their tissue specificity, which leaves room for improvement. This review discusses the properties of rAAV that make them useful tools in experimental studies and the treatment of cardio...Continue Reading

References

Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R M KotinK I Berns
Sep 22, 1999·Gene Therapy·N ChirmuleJ Wilson
Jan 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·M I MiyamotoR J Hajjar
Feb 23, 2000·Journal of Virology·J S BartlettR J Samulski
Aug 23, 2002·Proceedings of the National Academy of Sciences of the United States of America·Guang-Ping GaoJames M Wilson
Aug 13, 1965·Science·R W ATCHISONW M HAMMON
May 28, 2004·Journal of Virology·Guangping GaoJames M Wilson
Sep 1, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lingling DuPatricia A Thistlethwaite
Dec 1, 2004·Annual Review of Genetics·Douglas M McCartyR Jude Samulski
Jan 24, 2006·Nature Biotechnology·Narendra MaheshriDavid V Schaffer
Apr 10, 2007·Journal of the American College of Cardiology·Christian KupattPeter Boekstegers
Aug 23, 2007·Physiological Genomics·Sadakatsu IkedaWilliam T Pu
Sep 18, 2007·Genesis : the Journal of Genetics and Development·Mandar Deepak MuzumdarLiqun Luo
Nov 21, 2007·The Journal of Experimental Medicine·Matthias NahrendorfMikael J Pittet
Feb 13, 2008·European Journal of Immunology·Arturo Reyes-SandovalAdrian V S Hill
Mar 18, 2008·Journal of the American College of Cardiology·Yoshiaki KawaseRoger J Hajjar
Apr 17, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Carmela ZincarelliJoseph E Rabinowitz
Jan 13, 2009·The Journal of Infectious Diseases·Roberto CalcedoJames M Wilson
Feb 4, 2009·Molecular and Cellular Biology·Sadakatsu IkedaWilliam T Pu
Feb 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Lin YangXiao Xiao
Mar 31, 2009·Journal of Cardiac Failure·Brian E JaskiUNKNOWN Calcium Up-Regulation by Percutaneous Administration of Gene Therapy In Cardiac Disease (CUPID) Trial Investigators
Apr 1, 2009·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Eugenia RaichlinSudhir S Kushwaha
Apr 28, 2009·Advanced Drug Delivery Reviews·Knut StiegerFabienne Rolling
Jun 23, 2009·Journal of Molecular and Cellular Cardiology·Carolin KrausPatrick Most
Dec 17, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Jun-ichi SuzukiRyozo Nagai

❮ Previous
Next ❯

Citations

Feb 13, 2020·Cancers·Eric A Hendrickson
Nov 5, 2019·Journal of Tissue Engineering and Regenerative Medicine·Paula García-OlloquiBeatriz Pelacho
Feb 13, 2021·Cardiovascular Research·Paloma Nieto-MarínUNKNOWN I T A C A Consortium Investigators

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
biopsy
nuclear translocation
PCR
peptide
transgenic
gene knockout
gene knockouts

Clinical Trials Mentioned

NCT00534703

Software Mentioned

CUPID

Related Concepts

Related Feeds

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Related Papers

Seminars in Hematology
Lindsey A George, Patrick F Fogarty
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Ruian XuMatthew J During
IDrugs : the Investigational Drugs Journal
Michael HallekM Hörer
© 2022 Meta ULC. All rights reserved